Patients with and without loss of hepatitis B virus DNA after hepatitis B e antigen seroconversion have different virological characteristics

被引:14
|
作者
Misawa, N
Matsumoto, A
Tanaka, E
Rokuhara, A
Yoshizawa, K
Umemura, T
Maki, N
Kimura, T
Kiyosawa, K
机构
[1] Shinshu Univ, Sch Med, Dept Med, Matsumoto, Nagano 3908621, Japan
[2] Adv Life Sci Inst Inc, Wako, Saitama, Japan
[3] Shinshu Univ, Grad Sch Med, Inst Organ Transplants Reconstruct Med & Tissue E, Matsumoto, Nagano 3908621, Japan
关键词
HBV DNA; seroconversion; HBV core-related antigen; precore mutation; core promoter mutation;
D O I
10.1002/jmv.20505
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The characteristic differences between patients with and without loss of hepatitis B virus (HBV) DNA after achieving hepatitis B e antigen seroconversion were analyzed by comparing changes in HBV DNA and HBV core-related antigen levels during a period from 3 years before to 3 years after the seroconversion. Of the 24 seroconverters, 6 (inactive replication group) showed continuous loss of HBV DNA in serum after the seroconversion and the remaining 18 did not lose HBV DNA (active replication group). The HBV DNA level was similar between the two groups, while the HBV core-related antigen level was significantly lower in the active replication group than in the inactive replication group before the seroconversion. The levels of both HBV DNA and HBV core-related antigen decreased remarkably around the time of seroconversion in the inactive replication group, while these levels did not change or decreased slightly in the active replication group. After the seroconversion, the HBV DNA level was significantly higher in the active replication group than in the inactive replication group, while the HBV core-related antigen level was similarly low between the two groups. Because the serum level of HBV core-related antigen mainly reflects that of HBe antigen, the low level of HBV core-related antigen seen after seroconversion in both groups might have contributed to the occurrence of seroconversion. The precore and core promoter mutations which cause diminished excretion of hepatitis B e antigen were significantly more frequent in the active replication group than in the inactive replication group. It was therefore considered that the seroconversion was caused mainly by a decrease in viral replication in the inactive replication group, and mainly by a decrease in HBe antigen production in the active replication group.
引用
收藏
页码:68 / 73
页数:6
相关论文
共 50 条
  • [21] Quantitative measurement of hepatitis B virus DNA in different areas of hepatic lobules in patients with chronic hepatitis B
    Mishiro, T
    Hamamoto, S
    Furuta, K
    Ishimura, N
    Rumi, MAK
    Miyake, T
    Sato, S
    Ishihara, S
    Adachi, K
    Kinoshita, Y
    JOURNAL OF MEDICAL VIROLOGY, 2006, 78 (01) : 37 - 43
  • [22] Clinical and histological characteristics of chronic hepatitis B with negative hepatitis B e-antigen
    Peng, J
    Luo, KX
    Zhu, YF
    Guo, YB
    Zhang, L
    Hou, JL
    CHINESE MEDICAL JOURNAL, 2003, 116 (09) : 1312 - 1317
  • [23] Hepatitis B infection of the liver in chronic hepatitis C without detectable hepatitis B virus DNA in serum
    Mariscal, LF
    Rodríguez-Iñigo, E
    Bartolomé, J
    Castillo, I
    Ortiz-Movilla, N
    Navacerrada, C
    Pardo, M
    Pérez-Mota, A
    Graus, J
    Carreño, V
    JOURNAL OF MEDICAL VIROLOGY, 2004, 73 (02) : 177 - 186
  • [24] SIGNIFICANCE OF HEPATITIS-B CORE ANTIGEN IN THE LIVER IN PATIENTS WITH CHRONIC HEPATITIS-B AND ITS RELATION TO HEPATITIS-B VIRUS-DNA
    YOO, JY
    KIM, HY
    PARK, CK
    KHANG, SK
    JEONG, JW
    CHUNG, WK
    DIBISCEGLIE, AM
    HOOFNAGLE, JH
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1990, 5 (03) : 239 - 243
  • [25] Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea
    Yoo, BC
    Park, JW
    Kim, HJ
    Lee, DH
    Cha, YJ
    Park, SM
    JOURNAL OF HEPATOLOGY, 2003, 38 (01) : 98 - 103
  • [26] Systematic review and meta-analysis: Development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis e antigen seroconversion
    Zhou, T. -C.
    Lai, X.
    Feng, M. -H.
    Tang, Y.
    Zhang, L.
    Wei, J.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (10) : 1172 - 1179
  • [27] Cytokine and chemokine signatures associated with hepatitis B surface antigen loss in hepatitis B patients
    Yoshio, Sachiyo
    Mano, Yohei
    Doi, Hiroyoshi
    Shoji, Hirotaka
    Shimagaki, Tomonari
    Sakamoto, Yuzuru
    Kawai, Hironari
    Matsuda, Michitaka
    Mori, Taizo
    Osawa, Yosuke
    Korenaga, Masaaki
    Sugiyama, Masaya
    Mizokami, Masashi
    Mita, Eiji
    Katayama, Keiko
    Tanaka, Junko
    Kanto, Tatsuya
    JCI INSIGHT, 2018, 3 (20)
  • [28] Hepatitis B virus activity in patients with anti-hepatitis C virus antibody positivity and hepatitis B antigen positivity
    Haushofer, AC
    Hauer, R
    Brunner, H
    Köller, U
    Trubert-Exinger, D
    Halbmayer, WM
    Haas, J
    Kessler, HH
    JOURNAL OF CLINICAL VIROLOGY, 2002, 25 : S99 - S102
  • [29] Serum hepatitis B surface antigen quantification as a useful assessment for significant fibrosis in hepatitis B e antigen-positive hepatitis B virus carriers
    Xun, Yun-hao
    Zang, Guo-qing
    Guo, Jian-chun
    Yu, Xiu-li
    Liu, Hong
    Xiang, Jing
    Liu, Jing
    Shi, Jun-ping
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (11) : 1746 - 1755
  • [30] Viral factors correlate with hepatitis B e antigen seroconverson in patients with chronic hepatitis B
    Liu, Chun-Jen
    Chen, Pei-Jer
    Lai, Ming-Yang
    Lin, Feng-Yi
    Wang, Tzusan
    Kao, Jia-Horng
    Chen, Ding-Shinn
    LIVER INTERNATIONAL, 2006, 26 (08) : 949 - 955